Showing results (161-170 of 406) with videos related to

Sort By:
Pageof 41
Plos One|September 27, 2022
An objective, automated and robust scoring using fluorescence optical imaging to evaluate changes in micro-vascularisation indicating early arthritisLukas Zerweck, Michaela Köhm, Phuong-Ha Nguyen, et al.
Annals of the Rheumatic Diseases|November 5, 2014
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment periodPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Medical Microbiology and Immunology|February 14, 2015
Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologicsJens Verheyen, Kseniya Maizus, Eugen Feist, et al.
Rheumatology and Therapy|July 17, 2023
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid ArthritisGerd R Burmester, Laura C Coates, Stanley B Cohen, et al.
Nature Reviews. Disease Primers|February 9, 2018
Rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Anne Barton, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2012
The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokinesBiljana Smiljanovic, Joachim R Grün, Robert Biesen, et al.
Connective Tissue Research|January 21, 2012
The impact of Porphyromonas gingivalis lipids on apoptosis of primary human chondrocytesEric Röhner, Paula Hoff, Georg Matziolis, et al.
Rheumatology and Therapy|September 27, 2023
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European PatientsRieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, et al.
Lancet (London, England)|June 18, 2018
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trialGerd R Burmester, Joel M Kremer, Filip Van den Bosch, et al.
The Journal of Rheumatology|November 17, 2017
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III StudiesChristina Charles-Schoeman, Désirée van der Heijde, Gerd R Burmester, et al.
Pageof 41